1.Two Cases of Nephropathy in Association with Acute Rheumatic Fever.
Young Hi PARK ; Myoung Su CHANG ; Mi Ja YOON ; Shinna KIM
Journal of the Korean Pediatric Society 1987;30(1):102-107
No abstract available.
Rheumatic Fever*
2.A Review of Acute Rheumatic Fever and Rheumatic Heart Disease Research in Malaysia
Hung Liang-choo ; Nadia Rajaram
The Medical Journal of Malaysia 2016;71(3 Suppl.):79-86
A total of 39 titles related to rheumatic fever or rheumatic
heart disease in Malaysia were found with online literature
search dating back to their inceptions and through 2014.
Additional publications from conference journals were
included. Nine papers were selected based on clinical
relevance and future research implications.
There were no population-based studies on the incidence or
prevalence of ARF or RHD. In the 1980s, the incidence of
admission due to ARF ranged from 2 to 21.1 per 100 000
paediatric admission per year. The burden of disease was
significant in the adult population; 74.5% of patients with
RHD were female, of which 77.1% were in the reproductive
age group of 15-45 years old. Rheumatic mitral valve disease
constituted almost half (46.7%) of all mitral valve repairs,
ranging from 44.8 – 55.8 patients per year from 1997 – 2003.
From 2010-2012, mitral valve interventions increased to 184
per year, of which 85.7% were mitral valve repair.
In children with ARF, 25.4% - 41.7% had past history of
rheumatic fever or RHD. In patients with rheumatic mitral
valve disease undergoing surgical or medical interventions,
only 6% reported history of ARF, none had history of GABHS
pharyngitis or antibiotic prophylaxis. Only 44.7% of patients
with RHD on follow-up were on intramuscular benzathine
penicillin prophylaxis.
Overall, there is scarcity of publications on ARF and RHD in
Malaysia. Priority areas for research include determination
of the incidence and prevalence of ARF and RHD,
identification of high-risk populations, evaluation on the
implementation and adherence of secondary preventive
measures, identification of subclinical RHD especially
amongst the high-risk population, and a surveillance system
to monitor and evaluate preventive measures, disease
progression and outcomes.
Rheumatic Fever
;
Rheumatic Heart Disease
3.Clinical Observation on Acute Rheumatic Fever in Children.
Yong Sang YOO ; Won Ho KANG ; Jae Sook MA ; Tai Ju HWANG ; Ki Young LEE ; Sang Woo KIM
Journal of the Korean Pediatric Society 1986;29(4):20-26
No abstract available.
Child*
;
Humans
;
Rheumatic Fever*
4.Arterial stiffness during acute and recovery phases of children with rheumatic fever
Nik Nor Izah Nik Ibrahim ; Hayati Jaafar ; Aida Hanum Ghulam Rasool ; Abdul Rahim Wong
The Medical Journal of Malaysia 2016;71(1):23-25
Acute rheumatic fever (ARF) is associated with systemic
inflammation and arterial stiffness during the acute stage. It
has not been reported if arterial stiffness remains after
recovery. The aim of this study was to determine the arterial
stiffness during acute stage and 6 months after recovery
from ARF. Arterial stiffness was assessed by carotid femoral
pulse wave velocity (PWV) in 23 ARF patients during the
acute stage of ARF and 6 months later. Simultaneously,
erythrocyte sedimentation rate (ESR) and other
anthropometric measurements were taken during both
stages. There was a significant reduction in PWV; 6.5 (6.0,
7.45) m/s to 5.9 (5.38, 6.48) m/s, p=0.003 6 months after the
acute stage of ARF. Similarly, ESR was also significantly
reduced from 92.0 (37.5, 110.50) mm/hr to 7.0 (5.0, 16.0)
mm/hr, p=0.001. In conclusion, arterial stiffness improved 6
months after the acute stage with routine aspirin treatment;
this correlates well with the reduction in systemic
inflammation.
Rheumatic Fever
;
Vascular Stiffness
5.Clinical Observation of Rheumatic Fever and Rheumatic Heart Disease in Children.
Soon Don HONG ; Sung Ho CHA ; Chang Il AHN
Journal of the Korean Pediatric Society 1986;29(6):14-21
No abstract available.
Child*
;
Humans
;
Rheumatic Fever*
;
Rheumatic Heart Disease*
6.Pericardial Effusion in Patients with Rheumatic Fever.
In Suck SEO ; Hee Ju KIM ; Jae Ho LEE ; Yong Soo YOON ; Yong CHOI ; Chang Yee HONG
Journal of the Korean Pediatric Society 1982;25(12):1225-1233
No abstract available.
Humans
;
Pericardial Effusion*
;
Rheumatic Fever*
7.Evaluate result of injecting to prevent rheumatic fever degree 2 at the Pediatrics depaprtment of Thanh Nhan Hospital
Journal of Vietnamese Medicine 2005;311(6):15-20
Studying on 93 children from 6 to 15 years old who had Rheumatic fever, were injected to prevent rheumatic fever at 2nd level in Thanh Nhan Hospital from 1999 to 2003. The result showed that: in polyarthritic and chorea type, symptoms gradually decreased and disappeared, but common valvular lesions of severe carditis almost still existed. The recurrent rate was very low. The complications of disease were few and might, include: pain and hardening at injected site accounted for 12.9% of total patients and 2.56% of the times of injection. There were 5.38% of patients with mild allergy, accounted for 0.27% of the injection times. It must be on the alert against some dangerous complications as: embolism, anaphylactic shock, mortality… after injection benzathin penicillin
Rheumatic Fever
;
Preventive Medicine
;
Child
8.Diagnosis and treament of heart failure in rheumatic fever patients at Hai Phong children Hospital from 1995 to 2001
Journal of Vietnamese Medicine 2004;304(11):3-11
The study of 113 heart failure patients with rheumatic fever at Hai Phong Children Hospital from 1995 to 2001. Carditis encountered in rheumatic fever for the first time was 58%, however carditis in rheumatic fever since the second time was 100%. The valvular sequelea was only encountered in severe cases and the more the disease the more the valvular sequelea had, the common sequelea was mitral insuffisance (45.18%). 93.92% patients were out of heart failure. While the mortality rate was 3.54%. 100% patients were treated using anti inflammation and anti infection, so the parallel treatment: anti inflammation and anti infection were especially necessary
Heart Failure
;
Diagnosis
;
Therapeutics
;
Rheumatic Fever
;
Child
9.The Collaborative Clinical Analysis of 985 Cases of Rheumatic Fever and Rheumatic Carditis in Children for 10 Years(1978~1987) in Korea.
Sung Ho CHA ; Sang Young JEONG ; Du Bong LEE ; Kyong Su LEE ; Sang Bum LEE ; Tae Chan KWON ; Young Chang TOCKGO ; Chang Sung SOHN ; Keun Chan SOHN ; Young Kin HONG ; Chan Young KIM ; Chang Yee HONG ; Yong Soo YUN ; Hong Yun CHOI ; Chang Hwi KIM ; Chul Ho KIM ; Tae Ju HWANG ; Jae Suk MA ; Chan Uhul JOO ; Kyoo Hwan RHEE ; Hahng LEE
Journal of the Korean Pediatric Society 1989;32(12):1621-1631
No abstract available.
Child*
;
Humans
;
Korea*
;
Myocarditis*
;
Rheumatic Fever*
10.Serum DKK-1 level in the development of ankylosing spondylitis and rheumatic arthritis: a meta-analysis.
Li ZHANG ; Hui OUYANG ; Zhen XIE ; Zhi Hui LIANG ; Xiong Wen WU
Experimental & Molecular Medicine 2016;48(4):e228-
To explore the association of serum Dickkopf-1 (DKK-1) levels with the development of ankylosing spondylitis (AS) and rheumatic arthritis (RA) in humans, databases including PubMed, EBSCO, Springerlink, Ovid, WANFANG and China National Knowledge Infrastructure (CNKI) were searched to identify relevant studies. On the basis of rigorous inclusion and exclusion criteria, case–control studies of the relationships between serum DKK-1 levels and AS and RA published before December 2014 were enrolled. Statistical analyses were performed using Comprehensive Meta-analysis 2.0 (CMA 2.0). Seven case–control trials with a total of 300 AS patients, 136 RA patients and 232 healthy controls were included in this study. Meta-analysis results revealed that DKK-1 serum levels were significantly higher in AS patients than in normal controls (standard mean differences (s.m.d.)=0.301, 95% confidence interval (CI)=0.094–0.507, P=0.004), whereas no significant difference in DKK-1 serum levels was observed between RA patients and healthy controls (s.m.d.=0.798, 95% CI=−2.166–3.763, P=0.598). Serum DKK-1 level may be closely related to the development of AS but not of RA.
China
;
Humans
;
Rheumatic Fever*
;
Spondylitis, Ankylosing*